Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2021
Monod Bio is a pioneering life sciences company that specializes in AI-powered de novo protein design, focusing on the development of biosensors and research use only (RUO) tools. Their innovative platform leverages advanced computational protein engineering to create highly modular reporters and biosensors, enabling rapid, sensitive, and cost-effective analytical assays. Founded in 2022 as a spin-out from the University of Washington's Institute for Protein Design, Monod Bio is positioned at the forefront of biosensor innovation, with a strong founding team and state-of-the-art technology that enhances their market position in clinical diagnostics and life sciences tools.
Something looks off?